Sunday, September 13, 2009

Jim Cramer mention boosts Ceragon shares - Globes


Jim Cramer mention boosts Ceragon shares
Globes
In after-hours trading on Nasdaq the share jumped 12.5%. On the TASE the share was up 9.42% to NIS 29.50 by early afternoon trading today. ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Saturday, September 12, 2009

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Friday, September 11, 2009

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Regeneron ends Phase 3 trial for pancreatic cancer treatment - Albany Times Union


Regeneron ends Phase 3 trial for pancreatic cancer treatment
Albany Times Union
The company announced the discontinuation of the trial after the markets closed. In after-hours trading, shares were off another 88 cents to $21.00.

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Sanofi-Aventis, Regeneron End Phase III Trial Of Aflibercept - Wall Street Journal


Sanofi-Aventis, Regeneron End Phase III Trial Of Aflibercept
Wall Street Journal
Shares of Regeneron fell 3% to $21.23 in after-hours trading. Sanofi-Aventis' American depositary shares closed Friday at $35.05, up 0.4%, and were inactive ...

and more »

Regeneron, Sanofi drug fails against pancreatic cancer - Forexyard


Regeneron, Sanofi drug fails against pancreatic cancer
Forexyard
Shares of Regeneron, a biotechnology company based in Tarrytown, New York, fell almost 5 percent in after-hours trading, from their closing price on Friday ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor


AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...


Unusual Options Trading in Coca-Cola (KO)

Options volume in The Coca-Cola Cola (NYSE: KO) is much more active than normal.  Coke is not one of the more volatile names where you generally see options volume.  The September $52.50 CALLS traded 10,248 versus open interest of 7,588, the second day of large bullish call buying. Also, 12,000 OCT-2009 $52.50 calls trading and 4,967 OCT-2009..55 calls with both exceeding open interest.  Shares are definitely breaking out of consolidation here and look to be targeting above $52.50.  There does not appear to be any upcoming catalysts, but it is a name the Buffett is always involved with, and earnings should come before October options expiry.  This could be more of a major technical call and feeling that a soft drink tax is not coming with the health plan.

JOE KUNKLE, OptionsHawk.com


FedEx Exponential Volume Helping Comps (FDX, UPS, EXPD, UTIW)

FedEx Corporation (NYSE: FDX) is surging on its announcement that it raised guidance.  At 11:02 AM EST we have a 7.3% gain to $78.00 and we have already crossed over 4.75 million shares.  That is getting close to 150% of its average volume and is triple what we have normally seen by this time in the morning.  The 52-week trading range here is $34.02 to $96.65, but this was north of $100.00 less than two years ago.  Just to show how much this one has risen of late, the 50-day moving average is $64.85 and the 200-day moving average is $56.45.  This move today takes the stock to levels not seen since last October, and technically it looks like each dollar up is a move into relatively new territory.  This has now run 130% or more since the lows during that panic selling wave in early March.

The secondary direct play off of this is United Parcel Service, Inc. (NYSE: UPS), with a 4% gain to $58.68 and the 4.3 million share average daily volume has just been crossed.  Its 52-week trading range is $37.99 to $70.00.  Our other lesser stocks in the group which we use to track this are Expeditors International of Washington Inc. Â   (NASDAQ: EXPD) and UTI Worldwide, Inc. (NASDAQ: UTIW), both of which are up close to 4% but on surprisingly low trading volume.

-JON OGG


Action-sports-industry execs assemble for expo - San Diego Union Tribune


Action-sports-industry execs assemble for expo
San Diego Union Tribune
Shares of the San Diego company surged $2.30, or 13.7 percent, to $19 in after-hours trading yesterday. The stock closed up 21 cents at $16.70 in regular ...


Wheat Declines on Concern Supply to Outpace Demand, Corn Drops - Bloomberg


Wheat Declines on Concern Supply to Outpace Demand, Corn Drops
Bloomberg
December-delivery wheat added 0.3 percent to $4.60 a bushel in after-hours trading on the Chicago Board of Trade at 2:26 pm Singapore time, narrowing its ...

and more »

AIG Holding Up On Downgrade (AIG)

American International Group, Inc. (NYSE: AIG) is back in the soup…. Wells Fargo joined in on the downgrade brigade and took the stock down to Underperform from Market-Perform.  As we have already seen two key downgrades, it seems that traders are becoming jaded to the downgrades.  At 8:46 AM EST we have seen over 400,000 shares trade hands.  The average volume is 34 million shares but the volume in each of the last 10 days has been significantly higher than that average.  So far this is down less than 3% at $36.80.  With this being the third downgrade, we’d actually look for AIG to trade the direction of the market from wherever this stock is trading around 9:45 or 10:00 AM EST….  This one has also been in a $36 to $40 trading channel the last three days.  As a reminder, many traders have started using AIG put and call options to trade this because the stock often moves too fast.  -JON OGG


Action-sports-industry execs assemble for expo - San Diego Union Tribune


Action-sports-industry execs assemble for expo
San Diego Union Tribune
Shares of the San Diego company surged $2.30, or 13.7 percent, to $19 in after-hours trading yesterday. The stock closed up 21 cents at $16.70 in regular ...


RBY Rubicon Minerals Corporation - After Hours Trading Closed at 3.71 - TransWorldNews (press release)


RBY Rubicon Minerals Corporation - After Hours Trading Closed at 3.71
TransWorldNews (press release)
Rubicon Minerals Corporation is a Canada-based mineral exploration-stage company that explores for commercially viable gold and base metal deposits. ...


SA Seabridge Gold, Inc. - After Hours Trading Closed - TransWorldNews (press release)


SA Seabridge Gold, Inc. - After Hours Trading Closed
TransWorldNews (press release)
Seabridge Gold Inc. (Seabridge) is a development-stage company engaged in the acquisition and exploration of gold properties located in North America. ...

and more »

Thursday, September 10, 2009

S&P Rally Nears A Key Benchmark - Gold Seek


Gold Seek

S&P Rally Nears A Key Benchmark
Gold Seek
Yesterday, the futures got as close as 1044.00 before retreating slightly in after-hours trading. The S&Ps and other broad indexes have now closed higher ...


Steel Dynamics Boosts Q3 Earnings Outlook - Trading Markets (press release)


Steel Dynamics Boosts Q3 Earnings Outlook
Trading Markets (press release)
... closed Thursday's regular trading session at $17.86, up 59 cents or 3.42% and gained an additional 20 cents or 1.12% in after hours trading.

and more »

National Semiconductor Profit Falls; Beats Estimates - FOXBusiness


National Semiconductor Profit Falls; Beats Estimates
FOXBusiness
... still fell when compared to the year-ago period when it was 66.0%. Shares of National Semiconductor fell 22 cents or 1.38% to $15.75 in after-hours trading.

and more »

Major Altria Options… Dividend Capture Trading (MO)

We recently noted after Altria Group Inc. (NYSE: MO) raised its dividend that the dividend north of 7% would likely cause a huge dividend capture trading activity as te dividend date was before the expiration date of the September options.  Our little belief ended up being the understatement of the year.  Normally if you saw options activity like this, you would think that the stock was about to be acquired or that the company was going to get to start giving cigarettes out in machines at schools.  That isn’t the case, but you will be amazed at the options trading in the SEPT-2009 CALLS:

Strike Volume Â  OpenInt.
$15.00 Â   48,114 Â    1,982
$16.00 Â   112,109 Â    4,495
$17.00 Â   535,360 Â    17,039
$18.00 Â   664,058 Â    21,031

The total volume in the stock today was a mere 23.3 million shares, still above the 16 million average.  But the total leveraged amount of this if you just tallied up call volume would have been over 100 million shares… Don’t be fooled by that.  This was a dividend capture trade.

Jon C. Ogg
September 10, 2009


Covidien Sees Fiscal-2010 Sales Rising 4% To 7% - Wall Street Journal


Covidien Sees Fiscal-2010 Sales Rising 4% To 7%
Wall Street Journal
Covidien shares rose 1.5% to $39.95 in after-hours trading, when the company announced guidance for fiscal 2010, which runs through September next year. ...

and more »

IBM, EU Group Create Search Engine For Photos, Video, Music - Wall Street Journal


IBM, EU Group Create Search Engine For Photos, Video, Music
Wall Street Journal
... page after page of results until they find what they want. IBM's shares fell 7 cents to $117.60 in after-hours trading. The stock is up about 40% this year.

and more »

BioMarin Stock & Option Volume Goes Exponential (BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a name which comes up in the emerging and speculative biotech takeover list rather frequently, and today we are seeing some interest on speculators.  As of 1:10 PM EST we are now more than exponential on the volume alert after a quick CNBC tout by one of the Najarian brothers.  We have seen 5.3 million shares versus an average volume of 1.36 million shares.  Shares are up almost 10% at $18.03, and the 52-week trading range is $9.93 to $30.74.  The SEPT-2009 $17.50 CALLS have traded some 6,365 contracts today, versus an open interest of 344 contracts.  Even in the OCT-2009 $17.50 CALLS, these have traded 1,745 contracts today, versus an open interest of 770 contracts.

As our friends noted over at BioMedReports.com, this company is presenting data at the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2009 at 1:35 p.m. ET.

JON OGG


Markets McLovin' Apple & Steve Jobs - ITProPortal


Markets McLovin' Apple & Steve Jobs
ITProPortal
Apple shares rose in after hours trading in the US as the company looks set to wipe out the one percent it suffered yesterday to reach its highest share ...

and more »

Exponential Volume Continues in Delta Petroleum (DPTR)

Delta Petroleum Corp. (NASDAQ: DPTR) has been on a rampage on more than just heavy volume after the company had reportedly received approval to drill four new exploratory gas wells in Washington.  At 10:52 AM EST we have shares trading up another 9.5% at $3.32 on over 10.7 million shares.  The average volume is 4.7 million shares, but that figure was actually closer to 3.5 million before yesterday’s monstrous volume surge.  Its 52-week trading range will show just how zany this stock is: $0.88 to $21.95.

On Wednesday we saw some 63.9 million shares trade hands and it closed at $3.03, but that is a huge gain compared to the 11.1 million shares after a $2.28 close on Tuesday and after a $1.96 close on Friday.

Delta has been around almost longer than many trading careers if you are under 40 or 45 years old.  From 2006 to earlier in 2008, this one spent most of the time trading between $15.00 and $30.00.  The mudslide in the stock chart here started in summer of 2008 and all of these gains which seem to be ludicrous are minor when you compare it to where this one has been in the past for a stock that is still under $1 billion in market cap today.

Analysts expect losses for the next two years and its history of earnings and revenues is a spotty one, particularly as revenues are expected to be one-third to half of what they used to be.

JON C. OGG
SEPTEMBER 10, 2009


NEW YORK, Sept 10 (Reuters) - Some US stocks on the move on Thursday: - Forbes


NEW YORK, Sept 10 (Reuters) - Some US stocks on the move on Thursday:
Forbes
The stock surged in after-hours trading on Wednesday. The company affirmed its results for the fiscal year just ended to be at the low end of its previous ...

and more »

Yahoo! Surging on Upgrade (YHOO)

Yahoo! Inc. (NASDAQ: YHOO) is up on an analyst upgrade as BofA Merrill Lynch raised it to BUY from NEUTRAL.  Shares were originally up 2% but Carol Bartz gave a CNBC i-view outlining how good the Microsoft search pact is and how different teh company is from Google.  At 8:56 AM EST we have shares up 3.5% at $15.30 on over 650,000 shares. -JON OGG


Men's Wearhouse Defies the Odds - TheStreet.com (subscription)


Men's Wearhouse Defies the Odds
TheStreet.com (subscription)
The stock declined by 5% in after-hours trading. This can be attributed to lower-than-expected third-quarter guidance, and natural profit-taking. ...


Loyalty Program Forces Youbet.com to Restate Financials - Gaming Intelligence Group (registration)


Loyalty Program Forces Youbet.com to Restate Financials
Gaming Intelligence Group (registration)
Shares in Youbet.com (Co. Profile) (NASDAQ:UBET) are currently down 1.53% to $2.20 per share in after hours trading in New York/

and more »

Loyalty Program Forces Youbet.com to Restate Financials - Gaming Intelligence Group (registration)


Loyalty Program Forces Youbet.com to Restate Financials
Gaming Intelligence Group (registration)
Shares in Youbet.com (Co. Profile) (NASDAQ:UBET) are currently down 1.53% to $2.20 per share in after hours trading in New York/


Wednesday, September 9, 2009

Convergys Corporation Announces Exchange Offer of up to $125000000 ... - Reuters


Convergys Corporation Announces Exchange Offer of up to $125000000 ...
Reuters
The "daily VWAP" will be determined without regard to after-hours trading or any other trading outside of the regular trading session trading hours. ...

and more »

Navistar Turns In a Loss as Sales Drop 37% - Wall Street Journal


Navistar Turns In a Loss as Sales Drop 37%
Wall Street Journal
In after-hours trading Wednesday, shares of Navistar were down 4.1% to $43.80. Navistar reported a loss of $12 million, or 16 cents a share, for the quarter ...

and more »

Shuffle Master sees higher profit on cost-cutting - Las Vegas Sun


Shuffle Master sees higher profit on cost-cutting
Las Vegas Sun
... company this past March following the retirement of Mark Yoseloff. Shuffle Master shares rose 35 cents, or 4.5 percent, to $8.04 during after hours trading.

and more »

AFTER THE BELL-Altera falls after outlook - Interactive Investor


AFTER THE BELL-Altera falls after outlook
Interactive Investor
Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial ...

and more »

Navistar Swings To Q3 Loss, Cuts FY09 Earnings Outlook - Trading Markets (press release)


Navistar Swings To Q3 Loss, Cuts FY09 Earnings Outlook
Trading Markets (press release)
... over the past year, closed Wednesday's regular trading session at $45.68, up 13 cents. The stock is currently losing $1.88 or 4.12% in after hours trading.

and more »

Cincinnati Bell Turns Lower After The Bell - Trading Markets (press release)


Cincinnati Bell Turns Lower After The Bell
Trading Markets (press release)
Look up the PowerRating of CBB and see how it has performed over the past week as well as the current proprietary PowerRating. ...

and more »